person · Reporting owner
Kavanagh Kathleen Claire
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SenesTech, Inc.SNES · Entity 8221 | Director | July 01, 2022 | July 06, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SenesTech, Inc.
Report date July 01, 2022 · Filed July 06, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.30 · Expires 2027-07-01 | Direct | 142,668 |
Reported balance
After 2022-07-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-07-01 · Grant · Acquired 142,668 · Balance 142,668 F1: The option vests and becomes exercisable as to 25% of the total shares on the first day of each calendar quarter following the date of grant, with 100% of the options fully vested on the earlier of the first anniversary of the grant date or the first annual meeting of stockholders of the Company after the grant date (subject to the recipient's continued service to the Company through such vesting date). |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests and becomes exercisable as to 25% of the total shares on the first day of each calendar quarter following the date of grant, with 100% of the options fully vested on the earlier of the first anniversary of the grant date or the first annual meeting of stockholders of the Company after the grant date (subject to the recipient's continued service to the Company through such vesting date).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2022 Filed Jul 6, 2022 22:12 UTC | SenesTech, Inc. SNES · Entity 8221 | GrantStock Option (right to buy) · Derivative | 142,668 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001209191-22-041318 · doc4.xml · derivative · entry 1 Kavanagh Kathleen Claire · CIK 0001833100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,668 Underlying: Common Stock · 142,668 shares Expires 2027-07-01 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total shares on the first day of each calendar quarter following the date of grant, with 100% of the options fully vested on the earlier of the first anniversary of the grant date or the first annual meeting of stockholders of the Company after the grant date (subject to the recipient's continued service to the Company through such vesting date). Read SEC document |
| June 25, 2021 Filed Jun 29, 2021 22:32 UTC | SenesTech, Inc. SNES · Entity 8221 | GrantStock Option (right to buy) · Derivative | 45,368 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001225208-21-009709 · doc4.xml · derivative · entry 1 Kavanagh Kathleen Claire · CIK 0001833100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,368 Underlying: Common Stock · 45,368 shares Expires 2026-06-25 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total shares on the first day of each calendar quarter following the date of grant, with 100% of the options fully vested on earlier of the first anniversary of the grant date or the first annual meeting of stockholders of the Company after the grant date (subject to the recipient's continued service to the Company through such vesting date). Read SEC document |
| March 03, 2021 Filed Mar 8, 2021 17:25 UTC | SenesTech, Inc. SNES · Entity 8221 | GrantStock Option (right to buy) · Derivative | 1,070 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001225208-21-004831 · doc4.xml · derivative · entry 1 Kavanagh Kathleen Claire · CIK 0001833100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,070 Underlying: Common Stock · 1,070 shares Expires 2026-03-03 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total shares on April 1, 2021, and as to the remaining 75% of the total shares, the earlier of June 30, 2021 or the Company's annual meeting (subject to recipient's continued service to the Company through such vesting date). Read SEC document |
| November 05, 2020 Filed Nov 25, 2020 22:18 UTC | SenesTech, Inc. SNES · Entity 8221 | GrantStock Option (right to buy) · Derivative | 16,099 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001225208-20-013973 · doc4.xml · derivative · entry 1 Kavanagh Kathleen Claire · CIK 0001833100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,099 Underlying: Common Stock · 16,099 shares Expires 2025-11-05 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total shares on the first day of each calendar quarter following the date of grant provided that any portion remaining unvested as of June 30, 2021 will vest as of such date (subject to recipient's continued service to the Company through such vesting date). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.